Publications by authors named "A de Lossada"
Background: To assess the psychosocial impact of moderate-severe juvenile idiopathic arthritis (JIA) on patients and their families, among those who had been treated with at least one anti-tumor necrosis factor (anti-TNF-α), according to routine clinical practice in Spain.
Patients And Methods: A 24-month observational, multicentric, cross-sectional and retrospective study was performed. Children diagnosed with JIA were enrolled at three tertiary-care Spanish hospitals.
Article Synopsis
- Juvenile idiopathic arthritis (JIA) is a common chronic condition in children that can lead to serious long-term issues if not properly treated, highlighting the need for early intervention.
- A study in Spain assessed the costs associated with moderate-to-severe JIA in children, including both direct costs (like medication and doctor visits) and indirect costs (like travel and lost work hours for caregivers).
- Results showed that the average annual cost for treating JIA was €7516.40, with medication being the largest expense, mostly consisting of biologic treatments like adalimumab and etanercept.
Introduction: Smoking has been associated with an important health risk. The aim was to analyze the health-related quality of life (HRQoL) status of the adult Spanish general population included in the National Health Survey according to its smoking status.
Methods: Data were included from National Health Survey for the year 2011-2012 with information of HRQoL status in general population over 15 years of age.
Objective: To assess the cost-effectiveness of celecoxib and non-selective non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis in clinical practice in Spain.
Methods: A decision-tree model using distribution, doses, treatment duration and incidence of GI and CV events observed in the pragmatic PROBE-designed «GI-Reasons» trial was used for cost-effectiveness. Effectiveness was expressed in terms of event averted and quality-adjusted life-years (QALY) gained.